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Vikram Patel5 and Eugene Kinyanda6
Abstract
Background: The aim of this study was to determine the prevalence of neurological disorders and their associated
correlates and relations with clinical and behavioural problems among children and adolescents with HIV/AIDS (CA-HIV).
Methods: This study involved a sample of 1070 CA-HIV/caregiver dyads who were evaluated at their 6-month follow-up
visit as part of their participation in the longitudinal study, ‘Mental health among HIV infected CHildren and Adolescents in
KAmpala and Masaka, Uganda (the CHAKA study)’. Participants completed an extensive battery of measures that included
a standardized DSM-5- referenced rating scale, the parent version (5–18 years) of the Child and Adolescent Symptom
Inventory-5 (CASI-5). Using logistic regression, we estimated the prevalence of neurological disorders and characterised
their associations with negative clinical and behavioural factors.
Results: The overall prevalence of at least one neurological disorders was 18.5% (n = 198; 95% CI, 16.2–20.8). Enuresis /
encopresis was the most common (10%), followed by motor/vocal tics (5.3%); probable epilepsy was the least prevalent
(4%). Correlates associated with neurological disorders were in two domains: socio-demographic factors (age, ethnicity
and staying in rural areas) and HIV-related factors (baseline viral load suppression). Enuresis/encopresis was associated
with psychiatric comorbidity. Neurological disorders were associated with earlier onset of sexual intercourse (adjusted OR
4.06, 95% CI 1.26–13.1, P = 0.02).
Conclusions: Neurological disorders impact lives of many children and adolescents with HIV/AIDS. There is an urgent
need to integrate the delivery of mental and neurological health services into routine clinical care for children and
adolescents with HIV/AIDS in sub-Saharan Africa.
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Background
Children and adolescents infected with HIV/AIDS
(CA-HIV) are at increased risk of developmental and
neuropsychological disturbances owing to both the dir-
ect and indirect effects of the HIV virus [1, 2]. HIV has
direct neurotoxic effects on brain structures involved in
the regulation of emotion, behavior, and cognition, this
effect is thought to result primarily from HIV’s ability to
induce inflammatory factors that cause neuronal cell
damage and eventual cell death [1]. The indirect effects
of HIV include social stressors, poverty, illness and
trauma on morbidity and mortality [1, 2]. Previous re-
search suggests that HIV-1 mutations differ by subtype,
which may lead to increased resistance to anti-retroviral
therapy (ART) thus resulting in persistence of neuro-
logical and neurodevelopmental disorders among
CA-HIV receiving ART [2].
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In sub Saharan Africa, with the exception of epilepsy,
few studies have attempted to determine the prevalence
of neurologic disease among children and adolescents
and therefore characterize their clinical correlates [1]. In
one study conducted in East Africa, approximately
two-thirds of new patients presenting to a child and ado-
lescent psychiatry service had epilepsy [3], and seizures
are also common among individuals with HIV/AIDS [4].
Although neurological disorders are reported to be asso-
ciated with HIV/AIDS [1, 2, 5], no such studies have
been conducted among CA-HIV in Uganda. The pri-
mary objectives of the present study were to (a) docu-
ment the prevalence of neurological disorders among a
large sample of CA-HIV attending rural and urban HIV
clinics in Uganda, (b) characterize the relation of neuro-
logical disorders with a wide range of commonly studied
clinical correlates, (c) establish the co-occurrence of
neurological and psychiatric disorders, and (d) investi-
gate the relation of neurological disorders with import-
ant indices of functioning.
Methods
Participants
The study sample comprises 1070 CA-HIV and their care-
givers who were evaluated at their 6-month follow-up visit
as part of their participation in the Mental health among
HIV infected CHildren and Adolescents in KAmpala and
Masaka, Uganda (CHAKA) study. Details about the study
design, eligibility criteria and study procedures of CHAKA
are described in a previous publication [6]. Of the initial
1339 CA-HIV/ caregiver dyads interviewed at baseline,
269 (20.0%) were not included in the 6months analyses
for various reasons including: 3 had incomplete records
and the remaining 266 CA-HIV did not turn up for the 6
months follow-up interview despite various attempts to
reach them. Some of these later returned for their
12-month interview reporting that they had temporarily
transferred out of the study clinic.
Measures
The assessment battery comprised locally adapted stan-
dardised psychosocial instruments described in earlier
publications [6, 7] that have previously been used in the
USA [8–10]. Study variables reported in this paper are
described in Additional file 1 and are arranged according
to the conceptual framework depicted in Fig. 1.
Epilepsy
Probable clinical epilepsy was based on a score of yes to the
following item: Has this child/adolescent ever suffered re-
peated seizures or convulsions without fever being present?
Tic and elimination disorders
Motor tics and vocal tics and elimination disorders (en-
uresis and encopresis) were established using a clinically
practical, DSM-5-referenced, behaviour rating scale, the
Child and Adolescent Symptom Inventory-5 (CASI-5)
[10], which was previously used to study emotional and
behavioral disorders among CA-HIV in the United
States [9, 11]. The items in the CASI-5 are based on
symptom statements that appear in the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition
(DSM-5). Informants indicate whether these symptoms
occur, never, sometimes, often, or very often. CASI-5
items can be scored in several different ways, and in the
present study we used the symptom count cut-off score
Fig. 1 Conceptual framework for clinical correlates of neurological disorders
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for these items. Symptom count cut-off score indicates
whether child/adolescent has the prerequisite number of
symptoms necessary for a DSM-5 diagnosis, which for
this study was a rating of often or very often.
Psychiatric disorders
The CASI-5 also provides scoring algorithms for estimat-
ing psychiatric diagnoses. For purposes of this paper, we
generated clinical cutoff scores for 12 psychiatric disor-
ders, which we categorised as either internalising or exter-
nalising. The internalising disorder category included
generalised anxiety disorder, social anxiety disorder, separ-
ation anxiety disorder, specific phobia disorder, panic
disorder, post-traumatic stress disorder (PTSD), major
depressive episode (MDD and dysthymia). Externalising
disorders included attention-deficit/hyperactivity disorder
(ADHD), oppositional defiant disorder (ODD), conduct
disorder, and callous unemotional. To receive a clinical
cutoff score, a CA-HIV had to meet both DSM-based
symptom count criteria for a specific disorder as well as
impairment cutoff criteria. The latter is a rating of often or
very often to the question of whether symptoms inter-
ceded with social, academic, or chore-related functioning.
The CASI-5 was administered by trained psychiatric nurse
research assistants.
Sexual intercourse
Sexual intercourse was a response of yes to the question,
Have you ever had sex? Possible responses were yes/no,
this question was asked only to adolescents.
Statistical analysis
Prevalence estimates and 95% confidence intervals for
the three neurological outcomes of enuresis/encopresis,
motor or vocal tics and probable epilepsy are reported
overall and by age and gender category. Using a concep-
tual framework (Fig. 1) based on both HIV- and
non-HIV-related factors hypothesized to be associated
with neurological disorders, we investigated several
widely studied variables. Associations between each of
the neurological disorders evaluated at the 6-month
follow-up period, baseline socio-demographic and
HIV-related factors were undertaken using logistic re-
gression models. Multivariable models were selected
based on backward elimination, and models were fitted
sequentially to include significant factors from each
category at p < 0.1. The final model included the
pre-defined design variable of study site, age and sex and
all significant factors from the previous models.
The prevalence and 95% confidence intervals of comor-
bidities between neurological disorders as well as externa-
lising and internalising disorders were estimated. We
investigated associations of neurological disorders with
the following outcomes using logistic regression: social
outcomes as evidenced by disciplinary actions in school,
any missed days at school during the last term, and onset
of sexual intercourse (yes/no; adolescents only); and
health-related outcomes such as any visit to the health
unit in the last month; any hospital admissions in the last
6months, and non-adherence to ART defined as any
missed ART in the last 3 days (yes/no). For each outcome,
associations were assessed using logistic regression
models, adjusted for age, sex, study site and ethnicity. In
accordance with previously published work from the
CHAKA study, adjustment was made for CD4 cell count,
visits to the health unit, and hospital admissions and for
HIV ART status for the adherence outcome. Similarly, we
used 5% p-values for these descriptive exploratory analyses
because it is not clear how many comparisons should be
corrected for and precautions taken in interpretation due
to multiple comparisons. We used Bonferroni correction
adjusted p-values by multiplying the observed p value
from the significance tests by the number of tests k, for
each of the analyses with psychiatric symptom outcomes
[26, 27]. Then if any kP is less than 0.05 the differences in
the two groups (with versus those without neurological
disorders) are significant at the 0.05 level.
Results
Characteristics of study participants
Overall, the study included 677 (63.3%) children aged 5–
11 years and 393 (36.7%) adolescents aged 12–17 years.
The urban and rural study sites contributed equally. There
were slightly more females (52%) than males (48%). With
regard to HIV illness parameters, 88% had CD4 counts
equal or greater than 350 cells/μL, and most (95%) of the
participants were receiving ART (Additional File 2).
Prevalence of neurological disorders
One hundred ninety eight participants had at least one
neurological disorder (prevalence 18.5%). The prevalence
of neurological disorders was 10% for enuresis/encopre-
sis, 5.3% for motor/vocal tics, and 4% for probable epi-
lepsy (Table 1). Of the 198 with any neurological
disorder, 189 (17.7%) had at most one disorder [tics (n =
51, enuresis/encopresis (n = 102), and epilepsy (n = 36)],
and 9 (0.8%) had at most two disorders [tics and enur-
esis/encopresis (n = 2), tics and epilepsy (n = 4), enuresis/
encopresis and epilepsy (n = 3)]. The prevalence of any
neurological disorder was 18% in males and 19% in fe-
males. The prevalence of probable epilepsy among chil-
dren and adolescent was similar (4.0% vs. 4.1%), and
enuresis/encopresis was higher among children than ad-
olescents (14.0% vs. 3.1%), whereas motor/vocal tics
were more frequent among adolescents than children
(11% vs. 2%). Marginal gender differences in prevalence
of probable epilepsy in females versus males (5% vs 3%)
and in enuresis/encopresis in females versus males (9%
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vs 11%), whereas motor/vocal tics were more common
in females versus males (7% vs 4%).
Correlates of elimination disorders
Factors associated with enuresis/encopresis symptom
count cut-off scores in the multivariable model were
younger age (aOR 0.79, 95% CI 0.73–0.85, P < 0.001), eth-
nicity (being a non-Muganda with aOR of 0.56, CI 0.33–
0.95, P = 0.03), living in rural areas (aOR 2.25, CI 1.42–
3.54, P = 0.4), and less viral load suppression at baseline
(aOR 1.75, CI 1.08–2.83, P = 0.02) (Additional file 3).
Clinical correlates of motor and vocal tics)
CA-HIV socio-demographic variables associated with
motor/vocal tics symptom count cut off scores in the
multivariable model were increasing age (aOR 1.28, CI
1.17–1.40, P < 0.001) and ethnicity (being non-Muganda;
aOR 0.33, CI 0.14–0.76, P = 0.01) adjusted for site and
sex (Additional file 3).
Clinical correlates of probable epilepsy
We found ethnicity marginally associated with probable
epilepsy (being a non-Muganda with aOR of 1.87, CI
0.98–3.57, P = 0.06), adjusted for age, sex and site. None
of the other factors was associated with probable epi-
lepsy (p > 0.1) (Additional file 3).
Association with psychiatric symptoms
CA-HIV with enuresis/encopresis had a higher risk for
co-occurring externalising disorder (18.7%) and internalising
disorder (36.4%) (p < 0.001, and p < 0.001, respectively)
(Table 2). All the other associations between neurological
disorders and psychiatric comorbidities were not significant.
Association with social and academic functioning
Having any neurological disorder was associated with an
earlier onset of sexual intercourse (adjusted OR 4.06,
95% CI 1.26–13.1, P = 0.02). The relation of neurological
disorders with the other social or academic outcomes
were not significant (Table 3).
Discussion
This study aimed to determine the prevalence of neuro-
logical disorders among CA-HIV in Uganda and their as-
sociation with commonly studied mental health clinical
correlates, associated psychiatric comorbidities, and func-
tioning. The prevalence of at least one neurological dis-
order among CA-HIV was 18.5%, which is consistent with
findings from previous studies that suggest a high preva-
lence of neurological disorders among CA-HIV [2, 4].
The prevalence of probable epilepsy in this study was
4%, which is within the range reported in prior studies
both in the West and in South Africa. Kellinghaus and
colleagues (2008) found that among HIV positive adult
patients attending a neurological clinic in Germany,
6.1% had epilepsy [12]. Pascual-Sedano and colleagues
(1999) reported a 3% prevalence for new-onset seizures
during a one year follow-up period among an adult HIV
cohort in Spain [13]. In one of the few studies in this
area from sub-Saharan Africa, Samai and colleagues
Table 1 Prevalence and 95% CI of neurological disorders based on symptom counts cut-off scores of the CASI-5
Subgroup N Prevalence enuresis/
encopresis n (%) 95% CI
Prevalence motor/
vocal tics
Prevalence epilepsy Prevalence any
neurological disorder
Children 677 95 (14.0%) (11.4, 16.7) 14 (2.1%) (1.0, 3.1) 27 (4.0%) (2.5, 5.5) 131 (19.4%) (16.4, 22.3)
Adolescents 393 12 (3.1%) (1.3, 4.8) 43 (10.9%) (7.8, 14.0) 16 (4.1%) (2.1, 6.0) 67 (17.1%) (13.3, 20.8)
Female 550 48 (8.7%) (6.4, 11.1) 37 (6.7%) (4.6, 8.8) 26 (4.7%) (3.0, 6.5) 106 (19.3%) (16.0, 22.6)
Male 520 59 (11.3%) (8.6, 14.1) 20 (3.9%) (2.2, 5.5) 17 (3.3%) (1.7, 4.8) 92 (17.7%) (14.4, 21.0)
Overall 1070 107 (10%) (8.1, 11.8) 57 (5.3%) (4.0, 6.7) 43 (4.0%) (2.8, 5.2) 198 (18.5%) (16.2, 20.8)
Table 2 Comorbidities between neurological disorders with externalising and internalising psychiatric disorders
N = 1070 Enuresis/ Encopresis
n(%) CI, p-value
Motor/vocal tics Epilepsy Any neurological
disorder
n 107 57 43 198
Externalising disorder 20 (18.7%) 5 (8.8%) 4 (9.3%) 28 (14.1)
(12.4, 27.3) (3.6, 19.5) (3.6, 19.5) (9.9, 19.7)
P < 0.001 P = 0.9 P = 0.9 P = 0.01
Internalising disorder 39 (36.4%) 14 (24.6%) 14 (32.6%) 63 (31.8%)
(27.8, 46.0) (15.0, 37.4) (20.1, 25.2) (25.7, 38.7)
P < 0.001 P = 0.8 P = 0.1 P = 0.001
Externalising includes; any ADHD, ODD, CD, callous unemotional by symptom frequency, or clinically significant or interferes with function
Internalising; MDD, persistent dysthymia, GAD, panic disorder, specific phobia, PTSD, any social anxiety, separation anxiety,
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(2013) noted that among HIV positive youth in South
Africa, 7.6% had epilepsy [14].
The prevalence of enuresis/encopresis in this study
was 10%, and we were unable to locate any other studies
in the extant literature about these problems among
CA-HIV for purposes of comparison. A rate of enuresis
of 5–9% [15–17] and that of encopresis of 1–3% [15–17]
have been reported among general population samples
of children. In this study, the prevalence for motor/vocal
tics was 5.3%, a figure within the 4–12% range reported
among children in the general population [18].
In this study, the only variable that was marginally associ-
ated with probable epilepsy was ethnicity. Belonging to an
ethnic group that was not indigenous to the study area con-
ferred an increased risk for epilepsy. Ethnicity could be asso-
ciated with epilepsy for two reasons. Firstly, ethnicity may be
a pointer to the genetic underpinnings of epilepsy [19]. Sec-
ondly, ethnicity may be a marker for socio-economic disad-
vantage with respondents who were not indigenous to the
study area being more likely to experience medical complica-
tions while growing up that are associated with both social
disadvantage and epilepsy such as birth trauma, other central
nervous system infections (including complicated malaria),
and traumatic brain injury [20].
In this study, enuresis/encopresis were significantly asso-
ciated with younger age and marginally higher among
males than in females. Both enuresis and encopresis have
previously been reported to decrease with increasing age
[16, 21, 22] and to be higher among males than among fe-
males [21, 22]. In this study, enuresis/encopresis was sig-
nificantly associated with living in a rural area. Living in a
rural area was probably an index of low socio-economic
status. Indeed, in a Turkish study [16], enuresis was re-
ported to be associated with low maternal education and
with low monthly income, indices of poor socio-economic
status. Ethnicity was significantly associated with enuresis/
encopresis in this study. As previously discussed under
probable epilepsy, the association between enuresis/enco-
presis and ethnicity may be underlined by the same reasons
namely, as a pointer to an underlying genetic underpinning
for enuresis/encopresis [23], secondly, as a marker for
socio-economic disadvantage. The association between en-
uresis/encopresis and ‘less HIV viral load suppression’ ob-
served in this study may be due to the direct neurotoxic
effect of HIV or/ and to the increased psychological distress
associated with a worse HIV clinical state. Lastly, enuresis/
encopresis were the only neurological disorders significantly
associated with both externalising and internalising psychi-
atric disorders. Previous research has reported that 20–40%
of all children with enuresis have additional comorbid psy-
chiatric disorders which include the externalising disorders
of attention deficit hyperactivity disorder (ADHD) and
oppositional defiant disorder (ODD) and the internalising
disorder of depression [21]. In a large community study,
children with encopresis were reported to have increased
rates of the externalising disorders of ADHD and ODD and
the internalising disorders of separation anxiety, specific
phobia and generalised anxiety disorders [24].
In this study motor/vocal tics were more common in
females than in males. Scahill and colleagues (2014) in a
review involving eleven community studies reported
great variation in the female to male ratio of motor/
Table 3 Association between neurological disorders and adverse outcomes
Outcomes Enuresis/ Encopresis
aOR, p-valuea
Motor/ Vocal TICS
aOR, p-valuea
Epilepsy aOR,
p-valuea
Any neurological
disorder aOR, p-valuea
Any poor social functioning (Suffered disciplinary
measures ie suspension, dismissal)f
0.73 (0.16, 3.27) 0.71 (0.23, 2.15) 1.10 (0.43, 2.77) 1.06 (0.31, 3.61)
P = 0.7 P = 0.5 P = 0.8 P = 0.9
Any days missed at school in the last termf 0.89 (0.59, 1.35) 0.93 (0.67, 1.30) 1.35 (0.99, 1.85) 1.17 (0.78, 1.74)
P = 0.6 P = 0.7 P = 0.06 P = 0.4
Any visit to the health unit in the last monthc,f O.44 (0.17, 1.13) 0.57 (0.30, 1.06) 0.98 (0.59, 1.63) 1.39 (0.76, 2.56)
P = 0.09 P = 0.08 P = 0.9 P = 0.3
Any admission to hospital in last 6 monthsc,6 0.66 (0.15, 2.91) 0.94(0.34, 2.60) 0.85 (0.34, 2.13) 1.29 (0.44, 3.79)
P = 0.6 P = 0.9 P = 0.7 P = 0.6
Early onset of sexual intercourseb,e,f N/A 0.78 (0.26, 2.30) 1.87 (0.56, 6.21) 4.06 (1.26, 13.1)
P = 0.7 P = 0.3 P = 0.02
Any non-adherence to ART in last 3 daysb,d,f N/A 0.78 (0.33, 1.85) 1.21 (0.46, 3.21) 1.60 (0.55, 4.66)
P = 0.6 P = 0.7 P = 0.4
aAdjusted for age, sex, study site and ethnicity
bonly asked in adolescents,
cAdjusted for CD4 cell count at baseline
dNon adherence to ART adjusted for CD4 count at baseline and whether CA-HIV on ART
N/A – outcome does not vary
eBonferroni adjusted p value is 0.02*3 = 0.06
fBonferroni adjusted p value is > 0.1
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vocal tics ranging from 1 to 1, 1 to 4, through to 1 to 10
[25]. The factors significantly associated with motor/
vocal tics in this study included increasing age and eth-
nicity. Metzger and colleagues (2012) observed that as
children progress into young adulthood, tics often go
into remission [18]. The significant association between
motor/vocal tics and ethnicity as discussed under prob-
able epilepsy is probably underlined by two factors, a
genetic underpinning [26] and social disadvantage.
Having any neurological disorder in this study was as-
sociated with an earlier onset of sexual intercourse. The
reasons for this association were not immediately clear,
however this relationship could be mediated through
psychiatric comorbidity [6].
This study has several strengths that include a large sample
size, comprehensive assessment battery, and cross-cultural
orientation, however, there were also several limitations.
Firstly, it is not possible to comment on the casual direction
of obtained associations given the cross-sectional design.
Secondly, neurological disorders were assessed using single-
item questions which increased the risk of false positives.
Thirdly, because we did not have a comparable sample of
sero-negative youth from the same geographic areas, it is not
possible to know whether relations between neurological
and putative mental health factors and functional outcomes
are influenced by HIV status. This does not, however, detract
from the clinical implications of our findings for CA-HIV.
Lastly, by design, the present study focused on CA-HIV liv-
ing in Uganda, and owing to considerable cultural variation
in East Africa, our results may not be generalizable to other
countries in the region.
Conclusions
In summary, approximately 18% of CA-HIV living in
Uganda met DSM-5 symptom count plus impairment cri-
teria for neurological disorder. Risk factors of neurological
disorders among CA-HIV as hypothesised in the concep-
tual framework fell under two broad domains of HIV re-
lated factors (less viral load suppression at baseline) and
socio-demographic factors (age, gender, ethnicity and resi-
dence in the rural area). However, the association between
neurological disorders on one hand and ethnicity and exter-
nalising disorders on the other seem to suggest a genetic
vulnerability component. The association between ‘having a
neurological disorder’ and earlier age of sexual intercourse,
may have important implications for clinical management,
quality of life, long-term outcome and possible disease
transmission. Moving forward, there is a definite need to
integrate neurological/mental health services into routine
HIV care for youth in low-and middle-income settings such
as those in sub-Saharan Africa. This should include the de-
velopment of cost effective assessment and treatment strat-
egies that have high probability of success in challenging
interventional settings.
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